AAO: Glaucoma Drug Passes Early Clinical Test (CME/CE)
CHICAGO (MedPage Today) -- The first of a promising new class of glaucoma drugs reduced intraocular pressure and, perhaps more importantly, was additive with a current standard medication in a phase II trial, it was reported here.